Cargando…
Adherence to opioid agonist therapy predicts uptake of direct-acting antivirals in people who use drugs: results from the French national healthcare database (the ANRS FANTASIO study)
BACKGROUND: Opioid agonist therapy (OAT) is associated with reduced injection, reduced HCV transmission, and more opportunities to initiate hepatitis C virus (HCV) treatment in people who use drugs (PWUD). We aimed to study the extent to which adherence to OAT was predictive of increased uptake of d...
Autores principales: | Rolland, Benjamin, Lions, Caroline, Di Beo, Vincent, Carrieri, Patrizia, Authier, Nicolas, Barré, Tangui, Delorme, Jessica, Mathurin, Philippe, Bailly, François, Protopopescu, Camelia, Marcellin, Fabienne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9615191/ https://www.ncbi.nlm.nih.gov/pubmed/36303159 http://dx.doi.org/10.1186/s12954-022-00702-9 |
Ejemplares similares
-
Untreated alcohol use disorder in people who inject drugs (PWID) in France: a major barrier to HCV treatment uptake (the ANRS‐FANTASIO study)
por: Barré, Tangui, et al.
Publicado: (2019) -
Cannabis use as a factor of lower corpulence in hepatitis C-infected patients: results from the ANRS CO22 Hepather cohort
por: Barré, Tangui, et al.
Publicado: (2022) -
Depressive symptoms after hepatitis C cure and socio-behavioral correlates in aging people living with HIV (ANRS CO13 HEPAVIH)
por: Marcellin, Fabienne, et al.
Publicado: (2022) -
Cannabis Use Is Inversely Associated with Metabolic Disorders in Hepatitis C-Infected Patients (ANRS CO22 Hepather Cohort)
por: Barré, Tangui, et al.
Publicado: (2022) -
HCV cure: an appropriate moment to reduce cannabis use in people living with HIV? (ANRS CO13 HEPAVIH data)
por: Barré, Tangui, et al.
Publicado: (2022)